Previous 10 | Next 10 |
home / stock / hem:cc / hem:cc news
Calgary, Alberta--(Newsfile Corp. - September 15, 2022) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) ("Hemostemix" or the "Company") is pleased to announce the appointment of Dr. Johannes Grillari to its Scientific Advisory Board. Since 2019, Dr. Johannes Grillari is the director of the ...
Calgary, Alberta--(Newsfile Corp. - September 14, 2022) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) ("Hemostemix" or the "Company") is pleased to announce the appointment of Dr. Renzo Cecere, MD, FRCSC, to its Scientific Advisory Board. Dr. Cecere is the McGill University Chief of Cardiac Su...
Calgary, Alberta--(Newsfile Corp. - September 13, 2022) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) ("Hemostemix" or the "Company") is pleased to announce the appointment of Mr. Thomas Abraham, CA as President, PreCerv Inc. Mr. Abraham has more than 25 years of financing, business developme...
Calgary, Alberta--(Newsfile Corp. - August 31, 2022) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company") received numerous enquiries about the press release of August 30, 2022. This press release details the results in a table format and clarifies a misprin...
Calgary, Alberta--(Newsfile Corp. - August 30, 2022) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company") is pleased to announce the results of its Phase II Clinical Trial and the results of a new retrospective study of patients that underwent a trans-c...
Calgary, Alberta--(Newsfile Corp. - August 19, 2022) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) (" Hemostemix " or the " Company ") is pleased to announce a non-brokered private placement of up to five Million Units priced at $0.30 each, closing in tranches. Each Unit consists of...
Calgary, Alberta--(Newsfile Corp. - August 12, 2022) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (" Hemostemix " or the " Company ") announces that it has closed a second tranche of its previously announced non-brokered private placement of units (" Units ") as announced on Ma...
Calgary, Alberta--(Newsfile Corp. - June 22, 2022) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (" Hemostemix " or the " Company ") is pleased to announce it closed the first tranche of its non-brokered private placement of units (" Units ") announced on May 19, 2022, for gross proceeds of $69...
Calgary, Alberta--(Newsfile Corp. - June 14, 2022) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (" Hemostemix " or the " Company ") is pleased to announce it has incorporated PreCerv Inc. ("PreCerv"), as a wholly owned subsidiary. PreCerv will obtain from Hemostemix a global field of use licen...
Calgary, Alberta--(Newsfile Corp. - May 19, 2022) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (" Hemostemix " or the " Company ") is pleased to announce a non-brokered private placement of up to 15 Million Units priced in the context of the market. Each Unit consists of one common share in th...
News, Short Squeeze, Breakout and More Instantly...
Calgary, Alberta--(Newsfile Corp. - June 11, 2024) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) is pleased to announce it was notified by the World Intellectual Property Organization that it was granted the trademark Your Fountain of Youth by the Swiss Trademark Office. "In four h...
2024-06-03 13:23:23 ET In a press release this morning, %Hemostemix Inc. (TSXV: $HEM) (OTC: $HMTXF) announced it had signed a Letter of Intent ("LOI") with CytoImmune Therapeutics. The LOI will re-establish production of ACP-01 ("ACP") in CytoImmune's state-of-the-art clinical cell manu...
Calgary, Alberta--(Newsfile Corp. - June 3, 2024) - Hemostemix Inc. (TSXV: HEM) (OTC Pink: HMTXF) (FSE: 2VF0) is pleased to announce it has signed a Letter of Intent ("LOI") with CytoImmune Therapuetics ("CytoImmune") to re-establish production of ACP-01 ("ACP") in CytoImmune's state-of-the-art c...